RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Rallybio Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$16.35+0.07 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $94.80M
- P/E (TTM)
- 2.1
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 16, 2026(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Feb 6, 2026 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Nov 10, 2021(first seen in filings) | 25-for-4 | Earlier per-share figures divided by 6.25 |